Breaking News Instant updates and real-time market news.

NKE

Nike

$64.42

-1.93 (-2.91%)

, AMZN

Amazon.com

$1,544.92

-36.94 (-2.34%)

17:57
03/22/18
03/22
17:57
03/22/18
17:57

Nike says expanding product offerings on Amazon pilot

NKE

Nike

$64.42

-1.93 (-2.91%)

AMZN

Amazon.com

$1,544.92

-36.94 (-2.34%)

  • 22

    Mar

  • 22

    Mar

  • 16

    Apr

  • 17

    Apr

NKE Nike
$64.42

-1.93 (-2.91%)

03/12/18
FBCO
03/12/18
INITIATION
Target $78
FBCO
Outperform
Nike initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Binetti initiated Nike with an Outperform rating and a price target of $78. Binetti believes that revenue growth bottomed in Q1 and should accelerate to high single digits by FY19 driven by international sales from the start of World Cup, diminishing U.S. quality of sales headwinds, innovation in Running products, and improved Basketball segment sell-through. The analyst adds that his price target is derived from 18-times FY20 EBITDA forecast, which is in line with Nike's 3-year average valuation.
03/16/18
WEDB
03/16/18
NO CHANGE
Target $74
WEDB
Outperform
Nike CEO committing to stay a positive, says Wedbush
Wedbush analyst Christopher Svezia said he is encouraged by Nike's Mark Parker committing to stay in the CEO role beyond 2020, seeing the extended tenure as good for the company as it executes its Triple Double / 2X and Consumer Direct Offense strategies. Remarking on Nike Brand President Trevor Edwards' retirement, Svezia noted that media reports suggest that it may be related to issues having nothing to do with the company's underlying business and is likely not a sign of business deterioration. Svezia keeps an Outperform rating and $74 price target on Nike shares.
03/16/18
ADAM
03/16/18
NO CHANGE
Target $9
ADAM
Speculative Buy
Canaccord offers five reasons to sell Under Armour
Canaccord analyst Camilo Lyon gave five reasons to sell Under Armour (UA;UAA) shares and said the 2018 strategic plan is of great concern to him. Lyon said the off-price clearance is a band-aid; growth without innovation will be slow; its SKU count is being reduced, which will mute growth; consumer polls show its brand footwear growth is waning; and Nike (NKE) appears to be resurging. Lyon reiterated his Sell rating and $9 price target on Under Armour shares.
03/19/18
BOFA
03/19/18
NO CHANGE
Target $42
BOFA
Underperform
Nike valuation 'stretched' ahead of Q3 earnings, says BofA/Merrill
BofA/Merrill analyst Robert Ohmes keeps his Underperform rating with a $42 price target on Nike (NKE) ahead of the company's Q3 earnings this Thursday. Ohmes says that any potential EPS upside for the quarter will likely be offset by below-consensus guidance for Q4, as its current FY18 guidance of revenue growing at mid-single-digit pace is reliant on World Cup-related acceleration in revenue. The analyst contends that given the high expectations amid a challenging environment - evidenced by weak comps reported by Foot Locker (FL) and Finish Line (FINL) - there is a heightened risk of a sell-off.
AMZN Amazon.com
$1,544.92

-36.94 (-2.34%)

03/19/18
JMPS
03/19/18
NO CHANGE
Target $48
JMPS
Outperform
Any weakness in Cornerstone OnDemand a buying opportunity, says JMP Securities
JMP Securities analyst Patrick Walravens reiterated his Outperform rating and $48 price target on Cornerstone OnDemand (CSOD) after CNBC said last week that Amazon's (AMZN) Amazon Web Services is "considering a service for companies to show training content to their employees," and further suggested that Amazon had "explored the learning-management field and concluded that none of the available tools were just right for its own workers," that the company would "build its own system," and that the "idea was to build something 'commercializable.'" Walravens views any weakness in the stock from this news as a buying opportunity, as his due diligence with industry sources int he Cornerstone ecosystem "suggest that these concerns may be overblown."
03/20/18
OPCO
03/20/18
NO CHANGE
OPCO
Whole Foods/Amazon Prime Now difficult for grocers to match, says Oppenheimer
Oppenheimer analyst Rupesh Parikh spent time reviewing Amazon's physical grocery efforts including visiting three store types, namely Whole Foods location with Amazon Prime Now, Amazon Fresh grocery pickup, and Amazon Go. The analyst believes the Whole Foods/Amazon Prime Now offering with "free" delivery for Prime members represents potentially the most concerning development as its will be difficult for grocers to match.
03/20/18
CLVD
03/20/18
NO CHANGE
CLVD
Facebook pricing/ROI continuing higher, Twitter feedback constructive, says Cleveland Research
Citing a recent research into the digital advertising channel, Cleveland Research analyst Kevin Rottinghaus says that Facebook (FB) pricing continues to increase, justified by a continued improvement in ROI, and the social media platform appears to be opening more inventory on Instagram and Messenger. Meanwhile, the analyst says Twitter (TWTR) continues to improve in ad technology, advertiser/partner engagement, traffic and users, and the company is seeing some signs that ad dollars are coming back into the platform. Snap, on the other hand, is still seeing limited ad dollars to the platform as ROI and ad tech lag, with app redesign receiving cautious feedback, he contends. The analyst also pointed out that Amazon (AMZN) is viewed as taking incremental dollars otherwise likely to paid search and Google (GOOG; GOOGL), while remaining aggressive in expanding ad tech and sales channels.
03/21/18
ARGS
03/21/18
NO CHANGE
Target $61
ARGS
Buy
Oracle's soft Q4 cloud revenue view spooked the market, says Argus
Argus analyst Joseph Bonner writes that while Oracle (ORCL) posted a beat on Q3 earnings and revenue, along with a "remarkable" margin expansion, investors were spooked by lower than expected outlook for cloud revenue growth in Q4. The analyst contends that the company's key task is conversion of its blue-chip customer base to the cloud, as cloud computing becomes a standard in the next 3-5 years. Bonner adds that Oracle is also competing with "deep-pocketed" technology giants - Amazon (AMZN) Web Services, Microsoft's (MSFT) Azure, and Google (GOOG). The analyst remains positive on Oracle's prospects with a Buy rating and a $61 price target, pointing to the company's strong dividend growth, share buyback program, and below-peer valuation metrics.

TODAY'S FREE FLY STORIES

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Wynn Resorts sees opening Boston Harbor project in mid-2019 »

With its earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:13
04/25/18
04/25
08:13
04/25/18
08:13
Hot Stocks
Dare Bioscience, Juniper emter into exclusive worldwide license agreement »

Dare Bioscience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$189.70

-3.54 (-1.83%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Wynn Resorts CEO says Boston project not for sale »

Wynn Resorts CEO Matt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:12
04/25/18
04/25
08:12
04/25/18
08:12
Hot Stocks
Twitter CEO says soliciting external experts to improve health of service »

CEO Jack Dorsey said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

AVXS

AveXis

$210.76

0.77 (0.37%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
AveXis announces first patient dosed in Phase 3 trial of AVXS-101 »

AveXis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

PHM

PulteGroup

$29.66

0.84 (2.91%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Earnings
Hess Midstream Partners reaffirms FY18 net income view $335M-$360M »

Reaffirms FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CUE

Cue Biopharma

$13.45

-0.03 (-0.22%)

08:11
04/25/18
04/25
08:11
04/25/18
08:11
Hot Stocks
Cue Biopharma appoints Anish Suri, Ph.D. as Chief Scientific Officer »

Cue Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$201.16

-14.855 (-6.88%)

08:10
04/25/18
04/25
08:10
04/25/18
08:10
Recommendations
3M analyst commentary  »

3M price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 18

    May

  • 30

    May

CEMI

Chembio Diagnostics

$7.80

-0.05 (-0.64%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Hot Stocks
Chembio Diagnostics, LumiraDx enter collaboration for POC diagnostic tests »

Chembio Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 29

    May

EW

Edwards Lifesciences

$134.63

-2.59 (-1.89%)

08:09
04/25/18
04/25
08:09
04/25/18
08:09
Downgrade
Edwards Lifesciences rating change  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

INSE

Inspired Entertainment

$4.85

-0.4 (-7.62%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Inspired Entertainment signs games content agreement with Novomatic »

Inspired Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$42.96

-2.44 (-5.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Recommendations
Mercury Systems analyst commentary  »

Mercury Systems weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

HESM

Hess Midstream Partners

$19.49

-0.92 (-4.51%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Hess Midstream Partners reports Q1 EPS 30c, consensus 28c »

Reports Q1 revenue $157M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TWTR

Twitter

$30.48

-0.74 (-2.37%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Twitter: 'Privacy is a fundamental right for everyone we serve on our service' »

Comment taken from the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Hot Stocks
Amphenol increases dividend 21% to 23c per share, approves $2B buyback plan »

Amphenol's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

LKFN

Lakeland Financial

$48.90

0.46 (0.95%)

08:08
04/25/18
04/25
08:08
04/25/18
08:08
Earnings
Lakeland Financial reports Q1 EPS 71c, consensus 70c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$64.14

-0.25 (-0.39%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Periodicals
Icahn says Washington not for him, hasn't spoken with Trump in months »

"Neither I nor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$38.62

0.18 (0.47%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Hot Stocks
Hologic: FDA grants premarket approval for ThinPrep Integrated Imager »

Hologic announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 08

    May

  • 12

    Jun

CPF

Central Pacific

$31.00

0.63 (2.07%)

08:07
04/25/18
04/25
08:07
04/25/18
08:07
Earnings
Central Pacific reports Q1 EPS 48c, consensus 31c »

Reports Q1 NII $42.32M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:06
04/25/18
04/25
08:06
04/25/18
08:06
Earnings
Amphenol raises FY18 adjusted EPS view to $3.49-$3.55 from $3.39-$3.47 »

FY18 EPS consensus $3.46.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

, DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Hot Stocks
Juniper Pharmaceuticals licenses intravaginal ring platform to Dare Bioscience »

Juniper Pharmaceuticals…

JNP

Juniper Pharmaceuticals

$8.10

-0.6 (-6.90%)

DARE

Dare Bioscience

$0.82

0.0054 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$162.87

-2.38 (-1.44%)

08:05
04/25/18
04/25
08:05
04/25/18
08:05
Conference/Events
President Trump to meet with Apple CEO Cook »

The meeting between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

TZOO

Travelzoo

$7.75

0.2 (2.65%)

08:04
04/25/18
04/25
08:04
04/25/18
08:04
Earnings
Travelzoo reports Q1 EPS 20c, two estimates 8c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

APH

Amphenol

$82.76

-1.645 (-1.95%)

08:04
04/25/18
04/25
08:04
04/25/18
08:04
Earnings
Amphenol sees Q2 adjusted EPS of 83c-85c, consensus 85c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.